Carlyle-backed life sciences investor launches $1.5bn clinical trials fund
Abingworth, a UK-based life sciences investor backed by Carlyle, is raising up to $1.5bn for clinical trials and royalty partnerships ...
Abingworth, a UK-based life sciences investor backed by Carlyle, is raising up to $1.5bn for clinical trials and royalty partnerships ...
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.